Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Sales | 9,355,854 | 9,737,230 | 9,489,240 | 8,847,772 | 8,897,276 |
| Cost of Goods | 2,480,870 | 2,442,580 | 2,547,260 | 2,350,000 | 2,381,060 |
| Gross Profit | 7,267,330 | 7,297,610 | 7,235,139 | 6,756,750 | 6,966,030 |
| Operating Expenses | 5,314,500 | 4,896,220 | 5,542,100 | 4,859,400 | 5,098,920 |
| Operating Income | 1,561,354 | 2,399,010 | 1,400,141 | 1,638,373 | 1,417,356 |
| Interest Expense | 117,300 | 108,760 | 73,900 | 151,730 | 214,860 |
| Other Income | 426,036 | 40,950 | -711,371 | 323,997 | 51,484 |
| Pre-tax Income | 1,870,090 | 2,331,200 | 614,870 | 1,810,640 | 1,253,980 |
| Income Tax | 502,910 | 351,180 | -256,640 | 466,680 | 252,550 |
| Net Income Continuous | 1,520,882 | 2,013,470 | 741,750 | 2,178,300 | 2,250,392 |
| Net Income | $1,520,882 | $2,013,470 | $741,750 | $2,178,300 | $2,250,392 |
| EPS Basic Total Ops | 0.56 | 0.75 | 0.28 | 0.81 | 0.84 |
| EPS Basic Continuous Ops | 0.56 | 0.75 | 0.28 | 0.81 | 0.84 |
| EPS Diluted Total Ops | 0.56 | 0.75 | 0.28 | 0.81 | 0.84 |
| EPS Diluted Continuous Ops | 0.56 | 0.75 | 0.28 | 0.81 | 0.84 |
| EBITDA(a) | $1,561,354 | $2,399,010 | $1,400,141 | $1,638,373 | $1,417,356 |